NKTR logo

Nektar Therapeutics (NKTR) Total Assets

Annual Total Assets

$398.03 M
-$312.57 M-43.99%

31 December 2023

NKTR Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Assets

$307.97 M
-$35.37 M-10.30%

30 September 2024

NKTR Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NKTR Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-44.0%-30.4%
3 y3 years-74.1%-75.9%
5 y5 years-81.5%-85.3%

NKTR Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-74.1%at low-75.9%at low
5 y5 years-81.5%at low-85.3%at low
alltimeall time-81.5%+2214.2%-86.7%+4237.6%

Nektar Therapeutics Total Assets History

DateAnnualQuarterly
Sept 2024
-
$307.97 M(-10.3%)
June 2024
-
$343.33 M(-13.3%)
Mar 2024
-
$396.01 M(-0.5%)
Dec 2023
$398.03 M(-44.0%)
$398.03 M(-10.0%)
Sept 2023
-
$442.24 M(-10.5%)
June 2023
-
$494.28 M(-12.0%)
Mar 2023
-
$561.74 M(-20.9%)
Dec 2022
$710.60 M(-36.4%)
$710.60 M(-9.0%)
Sept 2022
-
$781.01 M(-9.4%)
June 2022
-
$861.99 M(-15.8%)
Mar 2022
-
$1.02 B(-8.3%)
Dec 2021
$1.12 B(-27.4%)
$1.12 B(-12.5%)
Sept 2021
-
$1.28 B(-6.9%)
June 2021
-
$1.37 B(-5.9%)
Mar 2021
-
$1.46 B(-5.3%)
Dec 2020
$1.54 B(-22.2%)
$1.54 B(+2.0%)
Sept 2020
-
$1.51 B(-5.4%)
June 2020
-
$1.59 B(-15.5%)
Mar 2020
-
$1.89 B(-4.5%)
Dec 2019
$1.98 B(-8.0%)
$1.98 B(-5.3%)
Sept 2019
-
$2.09 B(-0.5%)
June 2019
-
$2.10 B(-3.1%)
Mar 2019
-
$2.17 B(+0.8%)
Dec 2018
$2.15 B(+322.5%)
$2.15 B(-4.4%)
Sept 2018
-
$2.25 B(-2.8%)
June 2018
-
$2.31 B(+365.6%)
Mar 2018
-
$496.79 M(-2.4%)
Dec 2017
$508.87 M(-10.5%)
$508.87 M(-12.6%)
Sept 2017
-
$582.05 M(+22.3%)
June 2017
-
$475.86 M(-10.0%)
Mar 2017
-
$528.49 M(-7.1%)
Dec 2016
$568.87 M(+14.1%)
$568.87 M(+33.8%)
Sept 2016
-
$425.10 M(-8.2%)
June 2016
-
$463.10 M(-5.9%)
Mar 2016
-
$491.88 M(-1.4%)
Dec 2015
$498.64 M(+12.9%)
$498.64 M(+11.0%)
Sept 2015
-
$449.25 M(-1.6%)
June 2015
-
$456.67 M(-8.5%)
Mar 2015
-
$499.21 M(+13.0%)
Dec 2014
$441.62 M(+1.6%)
$441.62 M(-7.4%)
Sept 2014
-
$476.90 M(-0.3%)
June 2014
-
$478.14 M(-1.8%)
Mar 2014
-
$487.01 M(+12.1%)
Dec 2013
$434.53 M(-12.7%)
$434.53 M(+13.4%)
Sept 2013
-
$383.04 M(-7.2%)
June 2013
-
$412.81 M(-7.8%)
Mar 2013
-
$447.90 M(-10.0%)
Dec 2012
$497.79 M(-17.9%)
$497.79 M(-8.1%)
Sept 2012
-
$541.45 M(-19.0%)
June 2012
-
$668.44 M(-3.8%)
Mar 2012
-
$694.79 M(+14.5%)
Dec 2011
$606.55 M(+16.4%)
$606.55 M(-6.4%)
Sept 2011
-
$648.09 M(-3.4%)
June 2011
-
$670.85 M(-4.8%)
Mar 2011
-
$704.48 M(+35.2%)
Dec 2010
$521.23 M(-9.4%)
$521.23 M(+3.7%)
Sept 2010
-
$502.48 M(-5.3%)
June 2010
-
$530.64 M(-3.3%)
Mar 2010
-
$548.51 M(-4.7%)
Dec 2009
$575.52 M
$575.52 M(+27.1%)
Sept 2009
-
$452.65 M(-4.3%)
DateAnnualQuarterly
June 2009
-
$473.00 M(-6.5%)
Mar 2009
-
$505.94 M(-9.7%)
Dec 2008
$560.54 M(-22.7%)
$560.54 M(-1.4%)
Sept 2008
-
$568.35 M(-6.8%)
June 2008
-
$609.49 M(-5.3%)
Mar 2008
-
$643.84 M(-11.2%)
Dec 2007
$725.10 M(-5.6%)
$725.10 M(-1.8%)
Sept 2007
-
$738.28 M(+4.9%)
June 2007
-
$703.47 M(-1.4%)
Mar 2007
-
$713.74 M(-7.1%)
Dec 2006
$768.18 M(-10.5%)
$768.18 M(-2.8%)
Sept 2006
-
$790.02 M(-4.5%)
June 2006
-
$827.14 M(-1.7%)
Mar 2006
-
$841.54 M(-2.0%)
Dec 2005
$858.55 M(+15.3%)
$858.55 M(-9.3%)
Sept 2005
-
$946.91 M(+36.4%)
June 2005
-
$694.05 M(-2.8%)
Mar 2005
-
$714.19 M(-4.1%)
Dec 2004
$744.92 M(+20.8%)
$744.92 M(+0.5%)
Sept 2004
-
$741.10 M(-2.6%)
June 2004
-
$760.92 M(-3.3%)
Mar 2004
-
$787.13 M(+27.6%)
Dec 2003
$616.79 M(+1.7%)
$616.79 M(-2.5%)
Sept 2003
-
$632.92 M(-0.2%)
June 2003
-
$634.50 M(+12.5%)
Mar 2003
-
$563.94 M(-7.0%)
Dec 2002
$606.64 M(-9.1%)
$606.64 M(-3.2%)
Sept 2002
-
$626.53 M(-4.6%)
June 2002
-
$657.00 M(-3.5%)
Mar 2002
-
$680.79 M(+2.0%)
Dec 2001
$667.24 M(+6.0%)
$667.24 M(-2.7%)
Sept 2001
-
$685.68 M(-5.1%)
June 2001
-
$722.70 M(+5.2%)
Mar 2001
-
$687.14 M(+9.2%)
Dec 2000
$629.54 M(+177.6%)
$629.54 M(+49.8%)
Sept 2000
-
$420.32 M(-3.2%)
June 2000
-
$434.36 M(-3.1%)
Mar 2000
-
$448.29 M(+97.7%)
Dec 1999
$226.81 M(+68.6%)
$226.81 M(+86.9%)
Sept 1999
-
$121.37 M(-4.2%)
June 1999
-
$126.69 M(-3.5%)
Mar 1999
-
$131.35 M(-2.3%)
Dec 1998
$134.50 M(+12.3%)
$134.50 M(+31.1%)
Sept 1998
-
$102.60 M(-6.8%)
June 1998
-
$110.07 M(-3.3%)
Mar 1998
-
$113.87 M(-4.9%)
Dec 1997
$119.76 M(+188.6%)
$119.76 M(+60.0%)
Sept 1997
-
$74.85 M(+0.1%)
June 1997
-
$74.80 M(+2.4%)
Mar 1997
-
$73.02 M(+75.9%)
Dec 1996
$41.50 M(+78.9%)
$41.50 M(+12.8%)
Sept 1996
-
$36.80 M(-4.9%)
June 1996
-
$38.70 M(+82.5%)
Mar 1996
-
$21.20 M(-8.6%)
Dec 1995
$23.20 M(+34.9%)
$23.20 M(-7.2%)
Sept 1995
-
$25.00 M(-6.4%)
June 1995
-
$26.70 M(-6.3%)
Mar 1995
-
$28.50 M(+65.7%)
Dec 1994
$17.20 M
$17.20 M(-15.3%)
Sept 1994
-
$20.30 M(-2.9%)
June 1994
-
$20.90 M(+194.4%)
Mar 1994
-
$7.10 M

FAQ

  • What is Nektar Therapeutics annual total assets?
  • What is the all time high annual total assets for Nektar Therapeutics?
  • What is Nektar Therapeutics annual total assets year-on-year change?
  • What is Nektar Therapeutics quarterly total assets?
  • What is the all time high quarterly total assets for Nektar Therapeutics?
  • What is Nektar Therapeutics quarterly total assets year-on-year change?

What is Nektar Therapeutics annual total assets?

The current annual total assets of NKTR is $398.03 M

What is the all time high annual total assets for Nektar Therapeutics?

Nektar Therapeutics all-time high annual total assets is $2.15 B

What is Nektar Therapeutics annual total assets year-on-year change?

Over the past year, NKTR annual total assets has changed by -$312.57 M (-43.99%)

What is Nektar Therapeutics quarterly total assets?

The current quarterly total assets of NKTR is $307.97 M

What is the all time high quarterly total assets for Nektar Therapeutics?

Nektar Therapeutics all-time high quarterly total assets is $2.31 B

What is Nektar Therapeutics quarterly total assets year-on-year change?

Over the past year, NKTR quarterly total assets has changed by -$134.28 M (-30.36%)